The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and LeanLife Health are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak
Strong
Over the last 90 days LeanLife Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, LeanLife Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow
38.00
Total Cashflows From Investing Activities
-148.4 K
Free Cash Flow
-1.4 M
LeanLife
LeanLife Health Relative Risk vs. Return Landscape
If you would invest 0.50 in LeanLife Health on October 30, 2025 and sell it today you would earn a total of 0.00 from holding LeanLife Health or generate 0.0% return on investment over 90 days. LeanLife Health is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than LeanLife, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
Expected Return
Risk
LeanLife Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LeanLife Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LeanLife Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
LeanLife Health generated a negative expected return over the last 90 days
LeanLife Health has some characteristics of a very speculative penny stock
LeanLife Health has a very high chance of going through financial distress in the upcoming years
LeanLife Health has accumulated 747.4 K in total debt with debt to equity ratio (D/E) of 0.38, which is about average as compared to similar companies. LeanLife Health has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist LeanLife Health until it has trouble settling it off, either with new capital or with free cash flow. So, LeanLife Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like LeanLife Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for LeanLife to invest in growth at high rates of return. When we think about LeanLife Health's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (3.67 M) with profit before overhead, payroll, taxes, and interest of 0.
LeanLife Health has accumulated about 4.07 K in cash with (1.21 M) of positive cash flow from operations.
LeanLife Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LeanLife Pink Sheet often depends not only on the future outlook of the current and potential LeanLife Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LeanLife Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding
186.9 M
Short Long Term Debt
250 K
Shares Float
196.1 M
LeanLife Health Fundamentals Growth
LeanLife Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of LeanLife Health, and LeanLife Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LeanLife Pink Sheet performance.
By analyzing LeanLife Health's fundamental ratios, stakeholders can gain valuable insights into LeanLife Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if LeanLife Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LeanLife Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
LeanLife Health Inc. provides omega-3 plant-based oils worldwide. LeanLife Health Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada. Leanlife Health operates under Packaged Foods classification in the United States and is traded on OTC Exchange.
Things to note about LeanLife Health performance evaluation
Checking the ongoing alerts about LeanLife Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for LeanLife Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
LeanLife Health generated a negative expected return over the last 90 days
LeanLife Health has some characteristics of a very speculative penny stock
LeanLife Health has a very high chance of going through financial distress in the upcoming years
LeanLife Health has accumulated 747.4 K in total debt with debt to equity ratio (D/E) of 0.38, which is about average as compared to similar companies. LeanLife Health has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist LeanLife Health until it has trouble settling it off, either with new capital or with free cash flow. So, LeanLife Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like LeanLife Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for LeanLife to invest in growth at high rates of return. When we think about LeanLife Health's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (3.67 M) with profit before overhead, payroll, taxes, and interest of 0.
LeanLife Health has accumulated about 4.07 K in cash with (1.21 M) of positive cash flow from operations.
Evaluating LeanLife Health's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate LeanLife Health's pink sheet performance include:
Analyzing LeanLife Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LeanLife Health's stock is overvalued or undervalued compared to its peers.
Examining LeanLife Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating LeanLife Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LeanLife Health's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of LeanLife Health's pink sheet. These opinions can provide insight into LeanLife Health's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating LeanLife Health's pink sheet performance is not an exact science, and many factors can impact LeanLife Health's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Complementary Tools for LeanLife Pink Sheet analysis
When running LeanLife Health's price analysis, check to measure LeanLife Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeanLife Health is operating at the current time. Most of LeanLife Health's value examination focuses on studying past and present price action to predict the probability of LeanLife Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeanLife Health's price. Additionally, you may evaluate how the addition of LeanLife Health to your portfolios can decrease your overall portfolio volatility.